|
Schizophrenia
|
0.320 |
Biomarker
|
disease |
BEFREE |
Growing evidence suggests that the IgLON family of neural adhesion molecules LSAMP, NTM, NEGR1, and OPCML are important candidates in forming the susceptibility to schizophrenia (SCZ).
|
29434535 |
2018 |
|
Schizophrenia
|
0.320 |
Biomarker
|
disease |
PSYGENET |
The results showed significant allelic and haplotypic associations between LSAMP gene and schizophrenia.
|
24491686 |
2014 |
|
Schizophrenia
|
0.320 |
Biomarker
|
disease |
BEFREE |
The results showed significant allelic and haplotypic associations between LSAMP gene and schizophrenia.
|
24491686 |
2014 |
|
Unipolar Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder.
|
22892717 |
2012 |
|
Unipolar Depression
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder.
|
22892717 |
2012 |
|
Major Depressive Disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
The results showed a strong association between LSAMP SNPs and MDD, and a suggestive association between LSAMP SNPs and PD.
|
22892717 |
2012 |
|
Major Depressive Disorder
|
0.310 |
Biomarker
|
disease |
BEFREE |
The results showed a strong association between LSAMP SNPs and MDD, and a suggestive association between LSAMP SNPs and PD.
|
22892717 |
2012 |
|
Colorectal Neoplasms
|
0.110 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
|
26621817 |
2015 |
|
Malignant neoplasm of prostate
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.
|
26844274 |
2015 |
|
Malignant neoplasm of prostate
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies new prostate cancer susceptibility loci.
|
21743057 |
2011 |
|
Colorectal Neoplasms
|
0.110 |
AlteredExpression
|
group |
BEFREE |
LAMP proteins were expressed more intensely in the epithelium of colorectal neoplasms than in normal mucosa (P < 0.05), and no significant differences were found between adenoma and cancer cells (P > 0.05) in the same tissue section.
|
11485903 |
2001 |
|
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Specificity of TB-LAMP was similar to that of sputum smear microscopy (pooled specificity difference - 1·8, 95% CI -3·8 to + 0·2) and Xpert MTB/RIF (pooled specificity difference 0·5, 95% CI -0·9 to + 1·8).
|
30890135 |
2019 |
|
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
H-ALF exposed-M.tb growth within ATs was independent of M.tb-uptake, M.tb-trafficking, and M.tb-infection induced cytotoxicity; however, it was associated with enhanced bacterial replication within LAMP-1<sup>+</sup>/ABCA1<sup>+</sup> compartments.
|
30846830 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Melanoma LAMP-2C Modulates Tumor Growth and Autophagy.
|
30211163 |
2018 |
|
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Compared to MTB culture, overall sensitivity and specificity of TB-LAMP were 55.4% (95 CI 44.1-66.3) and 98.0% (95 CI 94.3-99.6) respectively.
|
29466946 |
2018 |
|
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
TB-LAMP could replace smear microscopy and increase TB diagnostic capacity when Xpert MTB/RIF is not feasible because of poor infrastructure.
|
29214755 |
2018 |
|
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
To evaluate the diagnostic performance of TB-LAMP, a manual molecular tuberculosis (TB) detection method, and provide comparison to the Xpert MTB/RIF assay.
|
29410366 |
2018 |
|
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Co-regulatory networks of human serum proteins link genetics to disease.
|
30072576 |
2018 |
|
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Here we present different examples about how LAMP proteins can influence and support tumor growth and metastatic spread, emphasizing the impact of each single member of the family.
|
29526252 |
2017 |
|
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Given its ease of operability, the TB-LAMP assay could be implemented as a point-of-care test in primary health care settings, and contribute to reducing treatment waiting times and TB prevalence.
|
28911361 |
2017 |
|
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our findings show the diagnostic utility of both GeneXpert and TB-LAMP in The Gambia.
|
26724771 |
2016 |
|
Malignant tumor of colon
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
|
26621817 |
2015 |
|
Colorectal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
|
26621817 |
2015 |
|
Endometrial Neoplasms
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
|
26621817 |
2015 |